Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-25

Clinical Trial Update: Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children [NA]

View source ↗

Summary

This is a completed clinical trial comparing nitazoxanide-based therapy with standard triple therapy for Helicobacter pylori infection in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitazoxanide (nitazoxanide)
  • Standard Helicobacter pylori eradication therapy (PPI + two antibiotics)

Snippet

Sponsor: Muhammad Aamir Latif | Conditions: Helicobacter Pylori Infection | NA | Status: COMPLETED